A. F. , Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding, 1999.

J. P. Anderson, D. E. Walker, and J. M. Goldstein, Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease, J. Biol. Chem, vol.281, pp.29739-29752, 2006.

V. L. Anderson, W. W. Webb, and D. Eliezer, Interplay between desolvation and secondary structure in mediating cosolvent and temperature induced alpha-synuclein aggregation, Phys. Biol, vol.9, p.56005, 2012.

F. Ar, Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding, 1999.

P. J. Barrett and J. T. Greenamyre, Post-translational modification of alpha-synuclein in Parkinson's disease, Brain Res, vol.1628, pp.247-253, 2015.

R. P. Bazinet and S. Laye, Polyunsaturated fatty acids and their metabolites in brain function and disease, Nat. Rev. Neurosci, vol.15, p.771, 2014.

L. Bousset, L. Pieri, and G. Ruiz-arlandis, Structural and functional characterization of two alpha-synuclein strains, Nat. Commun, vol.4, pp.1-13, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01183047

A. R. Braun, E. Sevcsik, P. Chin, E. Rhoades, S. Tristram-nagle et al., Alpha-synuclein induces both positive mean curvature and negative Gaussian curvature in membranes, J. Am. Chem. Soc, vol.134, pp.2613-2620, 2012.

A. R. Braun, M. M. Lacy, V. C. Ducas, E. Rhoades, and J. N. Sachs, Alpha-synuclein-induced membrane remodeling is driven by binding affinity, partition depth, and interleaflet order asymmetry, J. Am. Chem. Soc, vol.136, pp.9962-9972, 2014.

M. Brehme, C. Voisine, and T. Rolland, A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease, Cell Rep, vol.9, pp.1135-1150, 2014.

J. Burre, S. Vivona, J. Diao, M. Sharma, A. T. Brunger et al., Properties of native brain alpha-synuclein, Nature, vol.498, p.4, 2013.

E. Carboni and P. Lingor, Insights on the interaction of alphasynuclein and metals in the pathophysiology of Parkinson's disease, Metallomics, vol.7, pp.395-404, 2015.

R. J. Castellani, G. Perry, S. L. Siedlak, A. Nunomura, S. Shimohama et al., Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans, Neurosci. Lett, vol.319, pp.25-28, 2002.

M. S. Celej, R. Sarroukh, E. Goormaghtigh, G. D. Fidelio, J. M. Ruysschaert et al., Toxic prefibrillar alpha-synuclein amyloid oligomers adopt a distinctive antiparallel beta-sheet structure, Biochem. J, vol.443, pp.719-726, 2012.

L. Chen, M. Periquet, X. Wang, A. Negro, P. J. Mclean et al., Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation, J. Clin. Investig, vol.119, pp.3257-3265, 2009.

F. Chiti and C. M. Dobson, Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade, Annu. Rev. Biochem, vol.86, pp.27-68, 2017.

B. Choi, M. Choi, J. Kim, Y. Yang, Y. Lai et al., Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking, Proc. Natl Acad. Sci. USA, vol.110, pp.4087-92, 2013.

E. Colla, P. H. Jensen, O. Pletnikova, J. C. Troncoso, C. Glabe et al., Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo, J. Neurosci, vol.32, pp.3301-3305, 2012.

K. A. Conway, S. Lee, J. Rochet, T. T. Ding, R. E. Williamson et al., Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy, Proc. Natl Acad. Sci. USA, vol.97, pp.571-576, 2000.

K. A. Conway, S. J. Lee, J. C. Rochet, T. T. Ding, J. D. Harper et al., Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants, Ann. N. Y. Acad. Sci, vol.920, pp.42-45, 2000.

N. Cremades, S. I. Cohen, and E. Deas, Direct observation of the interconversion of normal and toxic forms of a-synuclein, Cell, vol.149, pp.1048-1059, 2012.

N. Cremades, S. W. Chen, and C. M. Dobson, Structural characteristics of alpha-synuclein oligomers, International Review of Cell and Molecular Biology, vol.329, pp.79-143, 2017.

K. M. Danzer, D. Haasen, A. R. Karow, S. Moussaud, M. Habeck et al., Different species of alpha-synuclein oligomers induce calcium influx and seeding, J. Neurosci, vol.27, pp.9220-9232, 2007.

K. M. Danzer, S. K. Krebs, M. Wolff, G. Birk, and B. Hengerer, Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology, J. Neurochem, vol.111, pp.192-203, 2009.

E. Deas, N. Cremades, and P. R. Angelova, Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease, Antioxid. Redox Signal, vol.24, pp.376-391, 2016.

F. Van-diggelen, D. Hrle, M. M. Apetri, G. Christiansen, G. Rammes et al., Two conformationally distinct in vitro a-synuclein oligomers share common epitopes and the ability to impair long-term potentiation, PLoS ONE, vol.14, 2019.

T. T. Ding, S. Lee, J. Rochet, and P. T. Lansbury, Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes, Biochemistry, vol.41, pp.10209-10217, 2002.

C. M. Dobson, Protein folding and misfolding, Nature, vol.426, p.884, 2003.

D. E. Ehrnhoefer, J. Bieschke, A. Boeddrich, M. Herbst, L. Masino et al., EGCG redirects amyloidogenic polypeptides into unstructured, offpathway oligomers, Nat. Struct. Mol. Biol, vol.15, p.558, 2008.

D. Eliezer, E. Kutluay, R. Bussell, . Jr, and G. Browne, Conformational properties of alpha-synuclein in its free and lipid-associated states, J. Mol. Biol, vol.307, pp.1061-1073, 2001.

H. Esterbauer, R. J. Schaur, and H. Zollner, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic, Biol. Med, vol.11, pp.81-128, 1991.

A. C. Ferreon, Y. Gambin, E. A. Lemke, and A. A. Deniz, Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence, Proc. Natl Acad. Sci. USA, vol.106, pp.5645-5650, 2009.

T. Finkel and N. J. Holbrook, Oxidants, oxidative stress and the biology of ageing, Nature, vol.408, p.239, 2000.

W. P. Flavin, L. Bousset, Z. C. Green, Y. Chu, S. Skarpathiotis et al., Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins, Acta Neuropathol, vol.134, pp.629-653, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01571238

D. Franceschi, G. Frare, E. Pivato, M. Relini, A. Penco et al., Structural and morphological characterization of aggregated species of alphasynuclein induced by docosahexaenoic acid, J. Biol. Chem, vol.286, pp.22262-22274, 2011.

A. K. Frimpong, R. R. Abzalimov, V. N. Uversky, and I. A. Kaltashov, Characterization of intrinsically disordered proteins with electrospray ionization mass spectrometry: conformational heterogeneity of a-synuclein, Proteins, vol.78, pp.714-722, 2010.

H. Fujiwara, M. Hasegawa, N. Dohmae, A. Kawashima, E. Masliah et al., Alpha-Synuclein is phosphorylated in synucleinopathy lesions, Nat. Cell Biol, vol.4, p.160, 2002.

G. Fusco, S. W. Chen, and P. T. Williamson, Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers, Science, vol.358, pp.1440-1443, 2017.

J. I. Gallea and M. S. Celej, Structural insights into amyloid oligomers of the Parkinson disease-related protein alpha-synuclein, J. Biol. Chem, vol.289, pp.26733-26742, 2014.

P. Garcia-esparcia, K. Hernndez-ortega, A. Koneti, L. Gil, R. Delgado-morales et al., Altered machinery of protein synthesis is region-and stage-dependent and is associated with alpha-synuclein oligomers in Parkinson's disease, Acta Neuropathol. Commun, vol.3, p.76, 2015.

L. Giehm, D. I. Svergun, D. E. Otzen, and B. Vestergaard, Lowresolution structure of a vesicle disrupting alpha-synuclein oligomer that accumulates during fibrillation, Proc. Natl Acad. Sci. USA, vol.108, pp.3246-3251, 2011.

S. Gribaudo, P. Tixador, L. Bousset, A. Fenyi, P. Lino et al., Propagation of alpha-synuclein strains within human reconstructed neuronal network, Stem Cell Rep, vol.12, pp.230-244, 2019.

R. Guerrero-ferreira, N. M. Taylor, D. Mona, P. Ringler, M. E. Lauer et al., Cryo-EM structure of alpha-synuclein fibrils, vol.7, p.36402, 2018.

A. Gustot, J. I. Gallea, R. Sarroukh, M. S. Celej, J. Ruysschaert et al., Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease, Biochem. J, vol.471, pp.323-333, 2015.

P. W. Ho, -. Leung, C. Liu, and H. , Age-dependent accumulation of oligomeric SNCA/alpha-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA), 2018.

R. Hodara, E. H. Norris, B. I. Giasson, A. J. Mishizen-eberz, D. R. Lynch et al., Functional consequences of alpha-synuclein tyrosine nitration diminished binding to lipid vesicles and increased fibril formation, J. Biol. Chem, vol.279, pp.47746-47753, 2004.

A. Hoffmann, B. Ettle, A. Bruno, A. Kulinich, A. Hoffmann et al., Alpha-synuclein activates BV2 microglia dependent on its aggregation state, Biochem. Biophys. Res. Comm, vol.479, pp.881-886, 2016.

S. Hyun-ju, L. E. Ju-hyun, C. Chang, and K. I. Jongsun, Copper (II)-induced self-oligomerization of a-synuclein, Biochem. J, vol.340, pp.821-828, 1999.

T. Ikenoue, Y. H. Lee, J. Kardos, M. Saiki, H. Yagi et al., Cold denaturation of alpha-synuclein amyloid fibrils, Angew. Chem. Int. Ed Engl, vol.53, pp.7799-7804, 2014.

M. Ingelsson, Alpha-synuclein oligomers-neurotoxic molecules in Parkinson's disease and other Lewy body disorders, Front. Neurosci, vol.10, p.408, 2016.

M. Kostka, T. Hogen, and K. M. Danzer, Single-particle characterization of iron-induced pore-forming alpha-synuclein oligomers, J. Biol. Chem, vol.283, pp.10992-1003, 2008.

R. Kruger, W. Kuhn, and T. Muller, AlaSOPro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet, vol.18, p.106, 1998.

M. Kurnik, C. Sahin, and C. B. Andersen, Novel a-synuclein aggregation inhibitors, identified by HTS, mainly target the monomeric state Cell, Chem. Biol, vol.25, pp.1389-1140, 2018.

H. A. Lashuel, B. M. Petre, J. Wall, M. Simon, R. J. Nowak et al., Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils, J. Mol. Biol, vol.322, pp.1089-1102, 2002.

H. A. Lashuel, C. R. Overk, A. Oueslati, and E. Masliah, The many faces of alpha-synuclein: from structure and toxicity to therapeutic target, Nat. Rev. Neurosci, vol.14, p.38, 2013.

S. H. Lee and I. A. Blair, Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation, Chem. Res. Toxicol, vol.13, pp.698-702, 2000.

C. Lee, H. J. Kim, J. Lee, H. Cho, J. Kim et al., Dequalinium-induced protofibril formation of alpha-synuclein, J. Biol. Chem, vol.281, pp.3463-3472, 2006.

S. Lesage, M. Anheim, and F. Letournel, G51D alphasynuclein mutation causes a novel Parkinsonian-pyramidal syndrome, Ann. Neurol, vol.73, pp.459-471, 2013.

B. Li, P. Ge, and K. A. Murray, Cryo-EM of full-length alphasynuclein reveals fibril polymorphs with a common structural kernel, Nat. Commun, vol.9, p.3609, 2018.

Y. Li, C. Zhao, and F. Luo, Amyloid fibril structure of alphasynuclein determined by cryo-electron microscopy, Cell Res, vol.28, pp.897-903, 2018.

E. Lindersson, R. Beedholm, P. Hojrup, T. Moos, W. Gai et al., Proteasomal inhibition by alpha-synuclein filaments and oligomers, J. Biol. Chem, vol.279, pp.12924-12958, 2004.

V. Lindstrom, T. Fagerqvist, and E. Nordstrom, Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice, Neurobiol. Dis, vol.69, pp.134-143, 2014.

Y. Liu, M. Qiang, Y. Wei, and R. He, A novel molecular mechanism for nitrated alpha-synuclein-induced cell death, J. Mol. Cell Biol, vol.3, pp.239-249, 2011.

T. Logan, J. Bendor, C. Toupin, K. Thorn, and R. H. Edwards, Alpha-synuclein promotes dilation of the exocytotic fusion pore, Nat. Neurosci, vol.20, p.681, 2017.

N. Lorenzen, S. B. Nielsen, and A. K. Buell, The role of stable alpha-synuclein oligomers in the molecular events underlying amyloid formation, J. Am. Chem. Soc, vol.136, pp.3859-3868, 2014.

N. Lorenzen, S. B. Nielsen, and Y. Yoshimura, How epigallogatechin gallate can inhibit a-synuclein oligomer toxicity in vitro, J. Biol. Chem, vol.289, pp.21299-21310, 2014.

K. C. Luk, C. Song, P. O'brien, A. Stieber, J. R. Branch et al., Exogenous alphasynuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells, Proc. Natl Acad. Sci. USA, vol.106, pp.20051-20056, 2009.

K. C. Luk, V. Kehm, J. Carroll, B. Zhang, P. O'brien et al., Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice, Science, vol.338, pp.949-953, 2012.

K. C. Luk, V. M. Kehm, B. Zhang, P. O'brien, J. Q. Trojanowski et al., Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative a-synucleinopathy in mice, J. Exp. Med, vol.209, pp.975-986, 2012.

N. C. Maiti, M. M. Apetri, M. G. Zagorski, P. R. Carey, and V. E. Anderson, Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein, J. Am. Chem. Soc, vol.126, pp.2399-2408, 2004.

M. Masuda-suzukake, T. Nonaka, M. Hosokawa, T. Oikawa, T. Arai et al., Prion-like spreading of pathological alpha-synuclein in brain, Brain, vol.136, pp.1128-1138, 2013.

N. Mizuno, J. Varkey, N. C. Kegulian, B. G. Hegde, N. Cheng et al., Remodeling of lipid vesicles into cylindrical micelles by alpha-synuclein in an extended alpha helical conformation, J. Biol. Chem, vol.287, pp.29301-29311, 2012.

R. I. Morimoto, The heat shock response: systems biology of proteotoxic stress in aging and disease, Cold Spring Harbor Symposia on Quantitative Biology, vol.76, pp.91-99, 2011.

A. Mougenot, S. Nicot, A. Bencsik, E. Morignat, J. Verchere et al., Prion-like acceleration of a synucleinopathy in a transgenic mouse model, Neurobiol. Aging, vol.33, pp.2225-2228, 2012.

T. Nasstrom, T. Fagerqvist, and M. Barbu, The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties. Free Radic, Biol. Med, vol.50, pp.428-437, 2011.

B. Nuscher, F. Kamp, T. Mehnert, S. Odoy, C. Haass et al., Alpha-synuclein has a high affinity for packing defects in a bilayer membrane a thermodynamics study, J. Biol. Chem, vol.279, pp.21966-21975, 2004.

F. Oosawa and S. Asakura, Thermodynamics of the Polymerization of Protein, 1975.

M. M. Ouberai, J. Wang, M. J. Swann, C. Galvagnion, T. Guilliams et al., Alpha-synuclein senses lipid packing defects and induces lateral expansion of lipids leading to membrane remodeling, J. Biol. Chem, vol.288, pp.20883-20895, 2013.

A. Oueslati, M. Fournier, and H. A. Lashuel, Role of posttranslational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies, Progress in Brain Research, vol.183, issue.10, pp.83007-83016, 2010.

K. E. Paleologou, A. Oueslati, and G. Shakked, Phosphorylation at S87 is enhanced in synucleinopathies, inhibits a-synuclein oligomerization, and influences synuclein-membrane interactions, J. Neurosci, vol.30, pp.3184-3198, 2010.

F. L. Palhano, J. Lee, N. P. Grimster, and J. W. Kelly, Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils, J. Am. Chem. Soc, vol.135, pp.7503-7510, 2013.

M. S. Parihar, A. Parihar, M. Fujita, M. Hashimoto, and P. Ghafourifar, Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells, Int. J. Biochem. Cell Biol, vol.41, pp.2015-2024, 2009.

W. Paslawski, M. Andreasen, S. B. Nielsen, N. Lorenzen, K. Thomsen et al., High stability and cooperative unfolding of cytotoxic a-synuclein oligomers, Biochemistry, vol.53, pp.6252-6263, 2014.

W. Paslawski, S. Mysling, K. Thomsen, T. J. Jørgensen, and D. E. Otzen, Co-existence of two different a-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry, Angew. Chem. Int. Ed Engl, vol.53, pp.7560-7563, 2014.

W. Paslawski, N. Lorenzen, and D. E. Otzen, Formation and characterization of a-synuclein oligomers, Methods Mol. Biol, vol.1345, pp.133-150, 2016.

W. Peelaerts, L. Bousset, A. Van-der-perren, A. Moskalyuk, R. Pulizzi et al., Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration, Nature, vol.522, p.340, 2015.

P. Ramos, J. M. Iribarren, P. Bousset, L. Melki, R. Baekelandt et al., Peripheral inflammation regulates CNS immune surveillance through the recruitment of inflammatory monocytes upon systemic alpha-synuclein administration, Front. Immunol, vol.10, p.80, 2019.

L. Pieri, K. Madiona, L. Bousset, and R. Melki, Fibrillar alphasynuclein and huntingtin exon 1 assemblies are toxic to the cells, Biophys. J, vol.102, pp.2894-2905, 2012.

L. Pieri, K. Madiona, and R. Melki, Structural and functional properties of prefibrillar alpha-synuclein oligomers, Sci. Rep, vol.6, p.24526, 2016.

M. H. Polymeropoulos, C. Lavedan, and E. Leroy, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, vol.276, pp.2045-2047, 1997.

I. M. Pranke, V. Morello, J. I. Bigay, K. Gibson, J. Verbavatz et al., Alpha-synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding, J. Cell. Biol, vol.194, pp.89-103, 2011.

C. Proukakis, C. G. Dudzik, T. Brier, D. S. Mackay, J. M. Cooper et al., A novel alpha-synuclein missense mutation in Parkinson disease, Neurology, vol.80, pp.1062-1064, 2013.

S. B. Prusiner, A. L. Woerman, and D. A. Mordes, Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism, Proc. Natl Acad. Sci. USA, vol.112, pp.5308-5317, 2015.

Z. Qin, D. Hu, S. Han, S. H. Reaney, D. A. Di-monte et al., Effect of 4-hydroxy-2-nonenal modification on alphasynuclein aggregation, J. Biol. Chem, vol.282, pp.5862-5870, 2007.

A. Recasens, B. Dehay, and J. Bove, Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys, Ann. Neurol, vol.75, pp.351-362, 2014.

N. L. Rey, G. H. Petit, L. Bousset, R. Melki, and P. Brundin, Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice, Acta Neuropathol, vol.126, pp.555-573, 2013.

N. L. Rey, J. A. Steiner, N. Maroof, K. C. Luk, Z. Madaj et al., Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease, J. Exp. Med, vol.213, pp.1759-1778, 2016.

B. D. Van-rooijen, K. A. Van-leijenhorst-groener, M. M. Claessens, and V. Subramaniam, Tryptophan fluorescence reveals structural features of alpha-synuclein oligomers, J. Mol. Biol, vol.394, pp.826-833, 2009.

M. Sandal, F. Valle, I. Tessari, S. Mammi, E. Bergantino et al., Conformational equilibria in monomeric a-synuclein at the single-molecule level, PLoS Biol, vol.6, p.6, 2008.

S. A. Semerdzhiev, S. Lindhoud, A. Stefanovic, V. Subramaniam, P. Van-der-schoot et al., Hydrophobic-Interaction-Induced Stiffening of alpha-Synuclein Fibril Networks, Phys. Rev. Lett, vol.120, p.208102, 2018.

A. Shimozawa, M. Ono, and D. Takahara, Propagation of pathological alpha-synuclein in marmoset brain, Acta Neuropathol. Commun, vol.5, p.12, 2017.

A. B. Singleton, M. Farrer, and J. Johnson, ) alpha-Synuclein locus triplication causes Parkinson's disease, Science, vol.302, p.841, 2003.

M. T. Stockl, N. Zijlstra, and V. Subramaniam, Alpha-synuclein oligomers: an amyloid pore?, Mol. Neurobiol, vol.47, pp.613-621, 2013.

F. Theillet, A. Binolfi, and B. Bekei, Structural disorder of monomeric alpha-synuclein persists in mammalian cells, Nature, vol.530, p.45, 2016.

M. D. Tuttle, G. Comellas, and A. J. Nieuwkoop, Solid-state NMR structure of a pathogenic fibril of full-length human alphasynuclein, Nat. Struct. Mol. Biol, vol.23, pp.409-415, 2016.

V. N. Uversky, A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders, J. Biomol. Struct. Dyn, vol.21, pp.211-234, 2003.

V. N. Uversky, J. Li, and A. L. Fink, Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein a possible molecular link between Parkinson's disease and heavy metal exposure, J. Biol. Chem, vol.276, pp.44284-44296, 2001.

J. Varkey, J. M. Isas, and N. Mizuno, Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins, J. Biol. Chem, vol.285, pp.32486-32493, 2010.

K. Vekrellis, M. Xilouri, E. Emmanouilidou, H. J. Rideout, and L. Stefanis, Pathological roles of alpha-synuclein in neurological disorders, Lancet Neurol, vol.10, pp.1015-1025, 2011.

M. J. Volles and P. T. Lansbury, Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's diseaselinked mutations and occurs by a pore-like mechanism, Biochemistry, vol.41, pp.4595-4602, 2002.

L. A. Volpicelli-daley, K. C. Luk, T. P. Patel, S. A. Tanik, D. M. Riddle et al., Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, vol.72, pp.57-71, 2011.

K. Wakabayashi, K. Tanji, F. Mori, and H. Takahashi, The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates, Neuropathology, vol.27, pp.494-506, 2007.

X. Wang, D. Moualla, J. A. Wright, and D. R. Brown, Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity, J. Neurochem, vol.113, pp.704-714, 2010.

J. C. Watts, K. Giles, A. Oehler, L. Middleton, D. T. Dexter et al., Transmission of multiple system atrophy prions to transgenic mice, Proc. Natl Acad. Sci. USA, vol.110, pp.19555-19560, 2013.

P. H. Weinreb, W. Zhen, A. W. Poon, K. A. Conway, and P. T. Lansbury, NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry, vol.35, pp.13709-13715, 1996.

B. Winner, R. Jappelli, and S. K. Maji, In vivo demonstration that alpha-synuclein oligomers are toxic, Proc. Natl Acad. Sci. USA, vol.108, pp.4194-4199, 2011.

G. Yamin, V. N. Uversky, and A. L. Fink, Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers, FEBS Lett, vol.542, pp.147-152, 2003.

A. Yoritaka, N. Hattori, K. Uchida, M. Tanaka, E. R. Stadtman et al., Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease, Proc. Natl Acad. Sci. USA, vol.93, pp.2696-2701, 1996.

J. J. Zarranz, J. Alegre, and J. C. Gomez-esteban, The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol, vol.55, pp.164-173, 2004.

N. Zijlstra, C. Blum, I. M. Segers-nolten, M. M. Claessens, and V. Subramaniam, Molecular composition of substoichiometrically labeled alpha-synuclein oligomers determined by single-molecule photobleaching, Angew. Chem, vol.124, pp.8951-8954, 2012.